Cediranib in ovarian cancer: state of the art and future perspectives.
Ruscito I, Gasparri ML, Marchetti C, De Medici C, Bracchi C, Palaia I, Imboden S, Mueller MD, Papadia A, Muzii L, Panici PB.
Ruscito I, et al. Among authors: papadia a.
Tumour Biol. 2016 Mar;37(3):2833-9. doi: 10.1007/s13277-015-4781-4. Epub 2016 Jan 11.
Tumour Biol. 2016.
PMID: 26753963
Review.